Every earnings call for NATHBIOGEN — management tone, guidance, KPIs and promise tracking, quarter by quarter.
NATHBIOGEN · 3 transcripts · Fast Moving Consumer Goods · latest Q4 FY26Nath Bio-Genes (India) Limited has 3 earnings calls on record here, a Fast Moving Consumer Goods company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue ₹432 cr (+19% YoY); EBITDA ₹52 cr; EBITDA Margin 12.0%. Total revenue grew 19% YoY to INR 431.6 crores.
Read full transcript & analysisRevenue 3199 million (+16% YoY); PAT 424 million (+15% YoY). H1 FY26 Revenue grew 15.9% YoY to INR3,199 million.
Read full transcript & analysisRevenue ₹362 cr (+9% YoY); EBITDA ₹52 cr (+4% YoY); PAT ₹42 cr (+13% YoY). Total revenue for FY25 stood at INR362.30 crores, with top line growth around 9% YoY.
Read full transcript & analysis